Target intelligence / Profile preview

RNA, U4 small nuclear 83, pseudogene (RNU4-83P)

Target
RNU4-83P
Molecular classification
Other (pseudogene of small nuclear RNA)
01

Overview

RNU4-83P (RNA, U4 small nuclear 83, pseudogene) is classified as a pseudogene for U4 spliceosomal RNA, a non-coding RNA component involved in the pre-mRNA splicing machinery called the spliceosome[3][7]. While canonical U4 snRNA participates in crucial regulatory steps in splicing by forming complexes with U6 and other spliceosomal proteins[1], pseudogenes like RNU4-83P are non-functional genomic copies that share sequence similarity with the functional U4 snRNA but do not encode an active molecule. Such pseudogenes generally do not produce functional RNA, are not involved in splicing, and are not considered therapeutic or molecular targets. They do not have recognized roles in disease, and no drugs interact with them. The existence of multiple related pseudogenes reflects the evolutionary history of small nuclear RNA gene families in the human genome[3][7]. Key clarification: - RNU4-83P is a pseudogene, not an active receptor, enzyme, or therapeutic target[3][7]. - It does not function in splicing or any other biological process and does not have clinical or pharmacological relevance. - There is nothing misspelled in the name, but as a pseudogene, it is not a relevant drug target. If you need information on the functional U4 snRNA or on pseudogene biology in general, please specify.

Other names
RNU4-83PU4 snRNA pseudogene 83U4 spliceosomal RNA pseudogene 83
02

Mechanism of action

None

03

Biological functions

None (pseudogene; no known biological function)
04

Disease associations

None (pseudogene; no direct disease associations)
05

Safety considerations

None
06

Interacting drugs

None
07

Biomarkers

None

Beyond the preview

Go deeper on RNA, U4 small nuclear 83, pseudogene (RNU4-83P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U4 small nuclear 83, pseudogene (RNU4-83P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call